Press Releases | Medtronic

Month Year

Email alerts

Mar 29, 2010

Newly Published Data Show Medtronic InterStim(R) Therapy Decreases Episodes of Chronic Fecal Incontinence and Positively Impacts Quality of Life

InterStim Therapy for Bowel Control Currently Under Review by the U.S. FDA

MINNEAPOLIS, Mar 29, 2010 (BUSINESS WIRE) --Data published in the March issue of the Annals of Surgery show that investigational use of sacral nerve stimulation with Medtronic InterStim(R) Therapy...
Mar 23, 2010

First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4] Medtronic, Inc. (NYSE: MDT) today announced the enrollment...
Mar 19, 2010

Medtronic Receives FDA Panel's Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System

Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment

MINNEAPOLIS, Mar 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
Mar 18, 2010

First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia

MINNEAPOLIS, Mar 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation...
Mar 17, 2010

Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management

Next Generation Integrated System - MiniMed Paradigm(R) REAL-Time Revel(TM) System - Incorporates Predictive Alerts to Help Patients More Tightly Control Diabetes

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time...
Mar 17, 2010

Medtronic Announces Next-Generation Pacing System for Use in MRI Machines Now Commercially Available in Selected European Geographies

Advisa DR MRI(TM) SureScan(TM) Represents the Most Advanced Pacing System from Medtronic that Combines MRI Compatibility with Exclusive Pacing Technology

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European...
Mar 17, 2010

Medtronic Completes Pre-Market Approval Submission to FDA for Arctic Front(R) Cardiac CryoAblation Catheter System

MINNEAPOLIS, Mar 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug...
Mar 16, 2010

Medtronic Introduces "Every Patient First" Initiative to Address Disparities in Access to Health Care

Partnerships with American College of Cardiology and Association of Black Cardiologists and Latest Data from IMPROVE HF Clinical Study All Aim to Drive Equitable Treatment

MINNEAPOLIS & ATLANTA, Mar 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced Every Patient First, a health equity initiative that, in partnership with health care providers,...
Mar 15, 2010

Medtronic CareLink(R) Network Remote Monitoring Significantly Reduced Time to Clinical Decision

Late Breaking Clinical Trial at 59th Annual Scientific Session of the American College of Cardiology (ACC) also Showed Shortened Cardiovascular Hospital Stays

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from the CONNECT trial showing the median time to clinical decision was significantly...
Mar 15, 2010

Medtronic Announces Initial Results of STOP AF Clinical Trial

Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...

Show per page